Swab

Swab both nostrils using medium pressure. Insert the swab approximately 1/2″-3/4″ (no deeper) and make at least 5 circles, swabbing the inner sides of each nostril. Take approximately 15 seconds per nostril.

Plunge

Immediately plunge the swab into the vial and slowly move it up and down for 10 seconds before leaving the swab to sit in the vial for 1 minute.

Pour

Place the test cassette on a flat level surface, remove the swab from the vial, squeezing out any excess liquid against the vial’s inner side, and pour all of the liquid content of the vial into the circular well on the test cassette.

Wait for results

Set a timer and read the result of the test after 20 minutes.

ASSURE-100 Rapid COVID-19 Home Tests

The ASSURE-100 Rapid COVID-19 Home Test delivers accurate and reliable results in just 20 minutes, using a shallow nasal swab for better comfort.

The test was developed in Hawaii by Oceanit, a technology company of just 200 people. in 2022, Oceanit was granted two FDA Authorizations for ASSURE-100 rapid tests, enabling the tests to be used by health care professionals around the world and at home without a prescription.

Founded in 1985 in Honolulu, Hawaii, Oceanit has earned a world-class reputation for breakthrough science and disruptive innovation built upon values of curiosity, community, and ohana. We are a skilled group of scientists, engineers, and innovators who tackle the world's most difficult problems.

Oceanit Foundry LLC is a subsidiary company of Oceanit Labs, Inc.

From Hawaii to the World.

The ASSURE-100 Rapid COVID-19 Home Test was authorized in December, 2022. It is developed by scientists and engineers in Honolulu, delivering a world-class diagnostic tool from Hawaii to the rest of the world.

Spread Aloha, NOT covid with the ASSURE-100 rapid COVID-19 test kit, developed by Oceanit in Honolulu, Hawai'i, USA. ASSURE-100 was granted two U.S. Food & Drug Administration Emergency Use Authorizations in 2022: 1. for point of care, and 2. for at-home (OTC) use. Oceanit is a Hawaii-based technology company that is concerned with protecting our communities from current and future COVID outbreaks.

ASSURE-100 rapid tests are available for purchase online and for local Hawai'i delivery or pickup. For bulk ordering, please contact us by clicking on the button below.

For use under FDA Emergency Use Authorization (EUA) only.

Self-Test at Home with ASSURE

New variants have shown that anyone can be vulnerable to COVID-19, even the young and the vaccinated. Early and frequent testing helps protect friends, family, and the community from potential exposure. With the ASSURE-100 Rapid COVID-19 Home Test, you can quickly and conveniently test yourself from the convenience of your home.

The ASSURE-100 Rapid COVID-19 Home Test provides accurate and reliable results in just 20 minutes using a lower nasal swab for better comfort.

For use under FDA Emergency Use Authorization (EUA) only.

Protect your Organization with ASSURE

The ASSURE Integrated Care Platform delivers a fast, accurate, and scalable solution for organizations of every type and size, from business to the public sector, schools, and more. Whether testing on-site or in employee homes, the simplicity of the ASSURE Rapid COVID-19 tests makes frequent, accurate testing seamless and intuitive, while the lower nasal swab makes it a more comfortable experience.

The ASSURE-100 Rapid COVID-19 Rapid Test is simple and intuitive, containing just three elements: the nasal swab, solution vial, and test cassette.

For use under FDA Emergency Use Authorization (EUA) only.

Spread Aloha, Not Covid with the ASSURE-100 Rapid Covid-19 Test

Keep your loved ones and community safe with Simple, Fast and Accurate testing.

Frequently Asked Questions

Frequently asked questions to help you learn more about ASSURE rapid tests.

1. What is ASSURE-100?

ASSURE-100 is a rapid COVID-19 test that uses an anterior nasal specimen to detect COVID-19, the disease caused by the SARS-CoV-2 virus. ASSURE is an acronym for: Accelerated Sensor Solution for Urgent Response to Epidemics.

2. Where was ASSURE-100 developed?

The ASSURE technology and ASSURE-100 rapid COVID-19 test was developed by Oceanit in Hawaiʻi and was put through testing and clinical trials in Hawaii and in other states across the US.

3. How do ASSURE tests work?

ASSURE-100 uses shallow nasal specimens to detect COVID-19 using a lateral flow assay (LFA) test cassette. A shallow anterior nasal swab specimen is mixed with buffer solution and then poured into the well on the test cassette. ASSURE tests are visually read, and do not require an external device to interpret results.

4. Does ASSURE-100 Rapid COVID-19 Home Test detect Omicron variants?

Yes, the ASSURE-100 Rapid COVID-19 Home Test clinical trial included BA.2.12.1 and BA.2 variant samples.  Additionally, the ASSURE-100 test was evaluated in a dilution series of clinical specimens positive for the Omicron variants BA.5 and BE.1.  This testing was conducted by National Institutes of Health (NIH) as a component of the Rapid Acceleration of Diagnostics (RADx) initiative.  Results indicate that ASSURE-100 detects both BA.5 and BE.1 variants.

5. How quickly will ASSURE-100 detect a result if positive?

Results should be read at 20 minutes.

Get in touch via email

If you have any questions please contact us at info@assure-test.com or by clicking the button below. Alternatively, you can get in touch by filling the contact form.

E-mail us

Contact us using the form below

    The ASSURE-100 Rapid COVID-19 POC Test is available by FDA Emergency Use Authorization (EUA) only. For more information click here.

    The ASSURE-100 Rapid COVID-19 POC Test that has been authorized by the U.S. FDA under an emergency use authorization for use by CLIA and CLIA waived laboratories in Point of Care settings. The ASSURE-100 Rapid COVID-19 Test is for use by authorized laboratories for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless authorization is terminated or revoked sooner. The ASSURE-100 Rapid COVID-19 Test has not been FDA approved.

    The ASSURE-100 Rapid COVID-19 Home Test is available by FDA Emergency Use Authorization (EUA) only. For more information click here.

    The ASSURE-100 Rapid COVID-19 Home Test has not been FDA cleared or approved, but has been authorized by FDA under an EUA; this product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; and, the emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb- 3(b)(1), unless the declaration is terminated or authorization is revoked sooner.